WeVote

Bill

WeVote Research Nonpartisan
Bill Summary · HB 6912

Summary — HB 6912: AN ACT ESTABLISHING AN ALZHEIMER'S DISEASE AND DEMENTIA TASK FORCE

Bill at a glance

  • Bill number: HB 6912 (File No. 111)
  • Title: An Act Establishing an Alzheimer's Disease and Dementia Task Force
  • Introduced: February 10, 2025
  • Subject areas: advisory bodies, Alzheimer's disease, dementia, plans, reports, task forces

Purpose / Intent

The bill would create a state-level task force focused on Alzheimer’s disease and other dementias. Its primary purpose is to bring together stakeholders to assess current services and supports, identify gaps in care and system capacity, and develop recommendations to improve prevention, diagnosis, care, caregiver support, workforce training, data collection and coordination of state programs.

Key provisions (what the bill would do)

Note: the bill text itself is not included here. Based on the title and standard practice for such measures, HB 6912 would generally:

  • Establish an advisory task force charged with studying Alzheimer’s disease and dementia-related needs across the state.
  • Require membership from state agencies, health care providers, researchers, long‑term care representatives, caregivers/advocates and possibly legislative members.
  • Direct the task force to review existing state services and programs, workforce capacity, access to diagnosis and treatment, long‑term care/residential services, caregiver supports, public awareness, and health equity concerns.
  • Direct the task force to develop recommendations (which may include a strategic plan, policy changes, and potential funding priorities) and to produce a report to the Governor and General Assembly.
  • Specify administrative details commonly found in similar bills (e.g., chair(s), meeting frequency, staffing, and an end date or a final reporting deadline).

Because the legislative text was not provided, specific membership numbers, reporting deadlines, and other technical details should be confirmed in the bill language.

Who would be affected

  • People living with Alzheimer’s disease and other dementias and their family caregivers.
  • Health care providers, long‑term care facilities, community service organizations and advocacy groups.
  • State agencies involved in public health, aging services, behavioral health, and long‑term care regulation.
  • Potentially insurers and municipal providers if recommendations lead to policy or funding changes.

Fiscal and procedural notes

  • The Office of Fiscal Analysis (OFA) was referred to the bill on March 11, 2025; any budgetary impact (meeting costs, staff support, research or implementation costs) will be quantified in OFA’s analysis.
  • Legislative actions to date:
    • Feb 10, 2025: Referred to Joint Committee on Aging
    • Feb 14, 2025: Public hearing held
    • Mar 4, 2025: Joint Favorable Substitute; filed with LCO
    • Mar 11, 2025: Referred to Office of Legislative Research and OFA
    • Mar 18, 2025: Reported out of LCO, favorably reported and tabled for House calendar (House Calendar No. 96; File No. 111)

Next steps would be floor consideration in the House, potential passage and then Senate consideration; if enacted, the task force would begin meeting per the bill’s specified timeline.

Where to find more detail

To see exact membership, duties, reporting deadlines and any sunset provisions, consult the bill text and the LCO file referenced as File No. 111 and the Office of Fiscal Analysis report when available.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.